Author Archive
Cooley, who also performed the first successful human heart transplant in the United States, founded the Texas Heart Institute and was one of the most celebrated heart surgeons in the world. The Texas native was also
By Scott Malone BOSTON (Reuters) - The doctors who patrol the sidelines of NFL games to assess whether injured players can safely return to the field should report to the league and players' union rather than
In what may be his last significant act as President Barack Obama's surgeon general, Dr. Vivek Murthy released a report Thursday calling for a major cultural shift in the way Americans view drug and alcohol addiction.
Blog submitted by Dane Levy Attorney of www.Dentalmal.com, a provider of legal services for those injured by dental malpractice in California Dental malpractice occurs when the dental treatment a person was offered is below the acceptable standard
By Kate Kelland LONDON (Reuters) - The number of people with high blood pressure has almost doubled in 40 years to over 1.1 billion worldwide, scientists said on Wednesday, with the burden of the condition shifting from
A spokesman for the European Commission, which is due to decide on the deal by Nov. 23, declined to comment. Abbott, which also makes prescription drugs and diagnostics, had no immediate comment. St. Jude officials could
Air maintenance workers at United Parcel Service Inc have voted overwhelmingly to authorize a strike against the world's largest package delivery company as contract talks remained deadlocked over health-care benefits, the workers' union said on Monday.
ALS results in loss of ability to communicate.
(Reuters) - The U.S. Food and Drug Administration rejected Dynavax Technologies Corp's marketing application for its hepatitis B vaccine, Heplisav-B, for the second time in three years, sending the company's shares tumbling 71 percent in premarket
(Reuters) - Johnson & Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Inc's top-selling Humira in a large trial. By one measure, patients with moderate to severe disease who took